Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 3.72% is 149% above its 5-year average of 1.50%, near the high end of its 5-year range (-23.98%–4.66%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.86% below its 12-month average of 4.17%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 3.72%.
RETURN ON INVESTED CAPITAL (ROIC)
3.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
4.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
1.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
1.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.86%
CURRENT VS 3Y AVG
+98.04%
CURRENT VS 5Y AVG
+148.67%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.33%
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
+113.61%
vs the sector median at left
GoodRx Holdings, Inc.
Market Cap
$1.16B
Return on Invested Capital (ROIC)
3.72%
TTM Avg
4.17%
3Y Avg
1.88%
5Y Avg
1.50%
Market Cap
$1.14B
Return on Invested Capital (ROIC)
1.81%
TTM Avg
7.83%
3Y Avg
4.30%
5Y Avg
3.30%
Market Cap
$1.14B
Return on Invested Capital (ROIC)
-42.98%
TTM Avg
-26.82%
3Y Avg
-23.95%
5Y Avg
-23.95%
Market Cap
$1.20B
Return on Invested Capital (ROIC)
-67.73%
TTM Avg
-67.73%
3Y Avg
-67.73%
5Y Avg
-67.73%
Market Cap
$1.12B
Return on Invested Capital (ROIC)
-6.33%
TTM Avg
-3.44%
3Y Avg
-10.34%
5Y Avg
-8.68%
Market Cap
$1.12B
Return on Invested Capital (ROIC)
5.93%
TTM Avg
9.95%
3Y Avg
11.37%
5Y Avg
9.31%
Market Cap
$1.21B
Return on Invested Capital (ROIC)
1.12%
TTM Avg
-4.20%
3Y Avg
-6.46%
5Y Avg
-10.06%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
9.48%
TTM Avg
1.29%
3Y Avg
-3.62%
5Y Avg
0.10%
Market Cap
$1.24B
Return on Invested Capital (ROIC)
-52.44%
TTM Avg
-96.82%
3Y Avg
-100.85%
5Y Avg
-77.97%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GoodRx Holdings, Inc. (GDRX) | $1.16B | 3.72% | 4.17% | 1.88% | 1.50% |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 1.81% | 7.83% | 4.30% | 3.30% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.14B | -42.98% | -26.82% | -23.95% | -23.95% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | -67.73% | -67.73% | -67.73% | -67.73% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | -6.33% | -3.44% | -10.34% | -8.68% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 5.93% | 9.95% | 11.37% | 9.31% |
| Cronos Group Inc. (CRON)vs › | $1.21B | 1.12% | -4.20% | -6.46% | -10.06% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 9.48% | 1.29% | -3.62% | 0.10% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.24B | -52.44% | -96.82% | -100.85% | -77.97% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -7.32% | -21.18% | -91.27% | -61.58% |
ROIC
3.7%
ROE
2.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 3.72% |
| 2026-03-31 | 3.99% |
| 2025-12-31 | 4.18% |
| 2025-09-30 | 4.31% |
| 2025-06-30 | 4.66% |
| 2025-03-31 | 4.07% |
| 2024-12-31 | 2.85% |
| 2024-09-30 | 2.36% |
| 2024-06-30 | -2.13% |
| 2024-03-31 | -2.30% |
| 2023-12-31 | -1.83% |
| 2023-09-30 | -0.44% |
| 2023-06-30 | 0.97% |
| 2023-03-31 | -0.43% |
| 2022-12-31 | 0.11% |
| 2022-09-30 | 0.79% |
| 2022-06-30 | 1.25% |
| 2022-03-31 | 1.41% |
| 2021-12-31 | 0.87% |
| 2021-09-30 | -19.23% |
| 2021-06-30 | -23.98% |
| 2021-03-31 | -22.30% |
| 2020-12-31 | -19.45% |
| 2020-09-30 | 3.93% |
| 2020-06-30 | 27.94% |
| 2019-12-31 | 32.05% |
